Loading
MP
Marinus Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 11 Feb 2025.
Marinus Pharmaceuticals, Inc.: what insiders have been doing
Marinus Pharmaceuticals, Inc. is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). No insider at Marinus Pharmaceuticals, Inc. has published a filing in the past twelve months. The most recent one dates from 11 February 2025.
Looking back to 2016, when coverage begins, insiders filed 2 purchases and 21 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
93
Thresholds
n/a
Buy Volume
€5,926
2 ops. · all time
Sell Volume
€393,420
21 ops. · all time
Who traded when
BuySaleElan Ezickson1 sale
Marvin Johnson1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 11 February 2025
Declarations93 total
12,186 shares@ US$0.5514.1% of flowCommon StockSEC:0001104659-25-011243:0
5,933 shares@ US$1.101.6% of flowCommon StockSEC:0001104659-25-011239:0
Canonical exit: 12 Nov 2024 (T+90)
9,398 shares@ US$0.55100.0% of flowCommon StockSEC:0001104659-25-011238:0
8,600 shares@ US$0.5545.8% of flowCommon StockSEC:0001104659-25-011248:0
12,707 shares@ US$0.5552.2% of flowCommon StockSEC:0001104659-25-011247:0
18,778 shares@ US$0.5516.4% of flowCommon StockSEC:0001104659-25-011240:0
5,389 shares@ US$0.5577.4% of flowCommon StockSEC:0001104659-25-011244:0
17,303 shares@ US$0.5513.7% of flowCommon StockSEC:0001104659-25-011241:0
4,600 shares@ US$0.55100.0% of flowCommon StockSEC:0001104659-25-011242:0
17,155 shares@ US$0.5513.9% of flowCommon StockSEC:0001104659-25-011246:0
1,600 shares@ US$0.548.3% of flowCommon StockSEC:0001415889-25-001930:0
1,610 shares@ US$0.5422.6% of flowCommon StockSEC:0001415889-25-001928:0
4,980 shares0Common StockSEC:0001415889-24-025070:0
4,828 shares@ US$1.137.6% of flowCommon StockSEC:0001415889-24-020895:0
3,621 shares@ US$1.138.2% of flowCommon StockSEC:0001415889-24-020897:0
12,145 shares@ US$1.133.3% of flowCommon StockSEC:0001415889-24-020894:0
4,657 shares@ US$1.137.2% of flowCommon StockSEC:0001415889-24-020898:0
3,820 shares@ US$1.146.6% of flowCommon StockSEC:0001415889-24-020899:0
2,300 shares0Common StockSEC:0001415889-24-017635:0
10,918 shares0Common StockSEC:0001415889-24-017632:0
2,300 shares0Common StockSEC:0001415889-24-017639:0
10,918 shares0Common StockSEC:0001415889-24-017631:0
37,300 shares0Common StockSEC:0001415889-24-017628:0
2,300 shares0Common StockSEC:0001415889-24-017638:0
2,300 shares0Common StockSEC:0001415889-24-017634:0
25 of 93 declarations
About Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc. is a company focused on developing treatments for neurological disorders. It is listed on the NASDAQ under the ticker MRNS.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
